{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:56:12Z","timestamp":1789944972598,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s11910-003-0073-2","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T09:55:08Z","timestamp":1188467708000},"page":"173-180","source":"Crossref","is-referenced-by-count":61,"title":["Sleep disturbances in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"3","author":[{"given":"Cynthia L.","family":"Comella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"73_CR1","volume-title":"An Essay on the Shaking Palsy","author":"J Parkinson","year":"1817","unstructured":"ParkinsonJ: An Essay on the Shaking Palsy. London: Whittingham and Rowland, 1817."},{"key":"73_CR2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.870130606","volume":"13","author":"E Tandberg","year":"1998","unstructured":"Tandberg E, Larsen JP, Karlsen K: A community-based study of sleep disorders patients with Parkinson\u2019s disease. Mov Disord 1998, 13:895\u2013899.","journal-title":"Mov Disord"},{"key":"73_CR3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00002826-198812000-00004","volume":"11","author":"AJ Lees","year":"1988","unstructured":"Lees AJ, Blackburn NA, Campbell VL: The night-time problems of Parkinson\u2019s disease. Clin Neuropharm 1988, 11:512\u2013519.","journal-title":"Clin Neuropharm"},{"issue":"suppl 1","key":"73_CR4","first-page":"220","volume":"40","author":"J Carter","year":"1990","unstructured":"Carter J, Carroll S, Lannon MC: Sleep disruption in untreated Parkinson\u2019s disease. Neurology 1990, 40(suppl 1):220.","journal-title":"Neurology"},{"key":"73_CR5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jnnp.66.4.431","volume":"66","author":"KH Karlsen","year":"1999","unstructured":"Karlsen KH, Larsen JP, Tandberg E, Maeland JG: Influence of clinical and demographic variables on quality of life in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 1999, 66:431\u2013435.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"73_CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1532-5415.1997.tb04506.x","volume":"45","author":"MC Smith","year":"1997","unstructured":"Smith MC, Ellgring H, Oertel WH: Sleep disturbances in Parkinson\u2019s disease patients and spouses. J Am Geriatr Soc 1997, 45:194\u2013199.","journal-title":"J Am Geriatr Soc"},{"key":"73_CR7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mds.870050404","volume":"5","author":"SA Factor","year":"1990","unstructured":"Factor SA, McAlarney T, Sanches-Ramos JR, Weiner WJ: Sleep disorders and sleep effect in Parkinson\u2019s disease. Mov Disord 1990, 5:280\u2013285.","journal-title":"Mov Disord"},{"key":"73_CR8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00005053-196808000-00012","volume":"147","author":"M Stern","year":"1968","unstructured":"Stern M, Roffwang H, Duvoisin R: The parkinsonian tremor in sleep. J Nerv Ment Dis 1968, 147:202\u2013210.","journal-title":"J Nerv Ment Dis"},{"key":"73_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.35.4.527","volume":"35","author":"JM Askenasy","year":"1985","unstructured":"Askenasy JM, Yahr MD: Reversal of sleep disturbance in Parkinson\u2019s Disease by antiparkinsonian therapy: a preliminary study. Neurology 1985, 35:527\u2013532.","journal-title":"Neurology"},{"key":"73_CR10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0404.1987.tb03546.x","volume":"76","author":"A Laihinen","year":"1987","unstructured":"Laihinen A, Alihanka J, Raitasuo S, Rinne UK: Sleep movements and associated autonomic nervous activities in patients with Parkinson\u2019s disease. Acta Neurol Scand 1987, 76:64\u201368.","journal-title":"Acta Neurol Scand"},{"key":"73_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1600-0404.2001.00024.x","volume":"104","author":"S Happe","year":"2001","unstructured":"Happe S, Schrode B, Faltl M, et al.: Sleep disorders and depression in patients with Parkinson disease. Acta Neurol Scand 2001, 104:275\u2013280.","journal-title":"Acta Neurol Scand"},{"key":"73_CR12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.49.2.393","volume":"49","author":"CH Adler","year":"1997","unstructured":"Adler CH, Sethi KD, Hauser RA, et al., for the Ropinirole Study Group: Ropinirole for the treatment of early Parkinson\u2019s disease. Neurology 1997, 49:393\u2013399.","journal-title":"Neurology"},{"key":"73_CR13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1212\/WNL.49.3.724","volume":"49","author":"KM Shannon","year":"1997","unstructured":"Shannon KM, Bennett JP, Friedman JH, for the Pramipexole Study Group: Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson\u2019s disease. Neurology 1997, 49:724\u2013728.","journal-title":"Neurology"},{"key":"73_CR14","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.29.9_Part_1.1253","volume":"29","author":"RP Lesser","year":"1979","unstructured":"Lesser RP, Fahn S, Snider S, et al.: Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 1979, 29:1253\u20131260.","journal-title":"Neurology"},{"key":"73_CR15","first-page":"107","volume-title":"Sleep: Neurotransmitters and Neuromodulators","author":"A Wauquier","year":"1985","unstructured":"Wauquier A, Clincke G, van den Broek W, de Prins E:Active and permissive roles of dopamine in sleep-wakefulness regulations. In Sleep: Neurotransmitters and Neuromodulators. Edited by WauquierJM, GaillardJ, MontiM, Radulovacki. New York: Raven Press; 1985:107\u2013120."},{"key":"73_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.287.4.455","volume":"287","author":"DE Hobson","year":"2002","unstructured":"Hobson DE, Lang AE, Martin WR, et al.: Excessive daytime sleepiness and sudden onset sleep in Parkinson\u2019s disease: s survey by the Canadian Movement Disorders Group. JAMA 2002, 287:455\u2013463. The largest series of Parkinson\u2019s disease patients assessed for excessive daytime sleepiness. This study provides a clinically usable intrument for office evaluation of excessive daytime sleepiness.","journal-title":"JAMA"},{"key":"73_CR17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archneur.1994.00540210094018","volume":"51","author":"B Hilten Van","year":"1994","unstructured":"Van Hilten B, Hoff JI, Middelkoop AM, et al.: Sleep disruption in Parkinson\u2019s disease. Arch Neurol 1994, 51:922\u2013928.","journal-title":"Arch Neurol"},{"key":"73_CR18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0013-4694(73)90174-0","volume":"35","author":"JC Gillin","year":"1973","unstructured":"Gillin JC, Post RM, Wyatt R, et al.: REM inhibitory effect of l-dopa infusion during human sleep. Electroenceph Clin Neurophys 1973, 35:181\u2013186.","journal-title":"Electroenceph Clin Neurophys"},{"key":"73_CR19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/228999a0","volume":"228","author":"RJ Wyatt","year":"1970","unstructured":"Wyatt RJ, Chase TN, Scott J, Snyder F: Effect of l-dopa on the sleep of man. Nature 1970, 228:999\u20131001.","journal-title":"Nature"},{"key":"73_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt1971122part2397","volume":"12","author":"A Kales","year":"1971","unstructured":"Kales A, Ansel RD, Markham CH, et al.: Sleep in patients with Parkinson\u2019s Disease and in normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971, 12:397\u2013406.","journal-title":"Clin Pharmacol Ther"},{"key":"73_CR21","first-page":"88","volume":"9","author":"HS Schmidt","year":"1972","unstructured":"Schmidt HS, Knopp W: Sleep in Parkinson\u2019s Disease: the effect of l-dopa. Psychophysiology 1972, 9:88\u201389.","journal-title":"Psychophysiology"},{"key":"73_CR22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.870100517","volume":"10","author":"AS Walters","year":"1995","unstructured":"WaltersAS, and the International Restless Legs Syndrome Study Group: Toward a better definition of the Restless Legs Syndrome. Move Disord 1995, 10:634\u2013642.","journal-title":"Move Disord"},{"key":"73_CR23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp.48.12.1240","volume":"48","author":"M Apps","year":"1985","unstructured":"Apps M, Shaff P, Ingram D, et al.: Respiration and sleep in Parkinson\u2019s Disease. J Neurol Neurosurg Psychiatry 1985, 48:1240\u20131245.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"73_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000213312","volume":"38","author":"L Ferini-Strambi","year":"1992","unstructured":"Ferini-Strambi L, Franceschi M, Pinto P, et al.: Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 1992, 38:92\u201398.","journal-title":"Gerontology"},{"key":"73_CR25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","volume":"58","author":"I Arnulf","year":"2002","unstructured":"Arnulf I, Konofal E, Merino-Amdreu M, et al.: Parkinson\u2019s disease and sleepiness. An integral part of PD. Neurology 2002, 58:1019\u20131024. This study provides evidence that suggests excessive daytime sleepiness as a part of Parkinsons\u2019s disease rather than solely an effect of external factors.","journal-title":"Neurology"},{"key":"73_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/sleep\/23.3.1c","volume":"23","author":"TC Wetter","year":"2000","unstructured":"Wetter TC, Collado-Seidel V, Pollmacjer T, et al.: Sleep and periodic leg movement patterns in drug-free patients with Parkinson\u2019s disease and multiple system atrophy. Sleep 2000, 23:361\u2013366. This study is one of the few that applies polysomnography to Parkinson\u2019s disease, multiple system atrophy, and normal aged-matched control subjects. It shows that rapid eye movement disorders are more common in the parkinsonian syndromes than normal subjects.","journal-title":"Sleep"},{"key":"73_CR27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(91)90002-6","volume":"40","author":"BE Jones","year":"1991","unstructured":"JonesBE: Paradoxical sleep and its chemical structural substrates in the brain. Neuroscience 1991, 40:637\u2013656.","journal-title":"Neuroscience"},{"key":"73_CR28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0030-6665(05)70124-9","volume":"32","author":"J Coleman","year":"1999","unstructured":"ColemanJ: Sleep apnea, part 2. Otolaryngol Clin North Am 1999, 32:195\u2013210.","journal-title":"Otolaryngol Clin North Am"},{"key":"73_CR29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(82)90835-6","volume":"239","author":"JC Hendricks","year":"1982","unstructured":"Hendricks JC, Morrison AR, Mann GL: Different behaviors during paradoxical sleep without atonia depends on pontine lesion site. Brain Res 1982, 239:81\u2013105.","journal-title":"Brain Res"},{"key":"73_CR30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","volume":"9","author":"CS Schenk","year":"1986","unstructured":"Schenk CS, Bundie SR, Ettinger MG, Mahowald MW: Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986, 9:293\u2013308.","journal-title":"Sleep"},{"key":"73_CR31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/sleep\/25.2.120","volume":"25","author":"CH Schenck","year":"2002","unstructured":"Schenck CH, Mahowald MW: REM sleep behavior disorder: clinical developmental and neuroscience perspectives 16 years after its formal identification in Sleep. Sleep 2002, 25:120\u2013138. This article reviews all of the salient features of rapid eye movement sleep behvior disorder and provides some intriguing suggestions as to pathophysiology.","journal-title":"Sleep"},{"key":"73_CR32","first-page":"177","volume-title":"The International Classification of Sleep Disorders","author":"American Sleep Disorders Association","year":"1990","unstructured":"American Sleep Disorders Association: REM sleep behavior disorder. InThe International Classification of Sleep Disorders. Kansas: Allen Press; 1990:177\u2013180."},{"key":"73_CR33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1212\/WNL.51.2.526","volume":"51","author":"CL Comella","year":"1998","unstructured":"Comella CL, Nardine TM, Diederich NJ, Stebbins GT: Sleeprelated violence, injury, and REM sleep behavior disorder in Parkinson\u2019s disease. Neurology 1998, 51:526\u2013529.","journal-title":"Neurology"},{"key":"73_CR34","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1176\/ajp.146.9.1166","volume":"146","author":"CH Schenck","year":"1989","unstructured":"Schenck CH, Milner DM, Hurwitz TD, et al.: A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry 1989, 146:1166\u20131173.","journal-title":"Am J Psychiatry"},{"key":"73_CR35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1212\/WNL.55.2.281","volume":"55","author":"I Arnulf","year":"2000","unstructured":"Arnulf I, Bonnet AM, Damier P, et al.: Hallucinations, REM sleep, and Parkinson\u2019s disease. A medical hypothesis. Neurology 2000, 55:281\u2013288. This study is the first to associate the occurrence of rapid eye movement sleep intrusions with delusions in Parkinson\u2019s disease patients on dopaminergic medications by comparing hallucinating patients to nonhallucinating patients using polysomnography and multiple sleep latency test.","journal-title":"Neurology"},{"key":"73_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-510X(01)00480-4","volume":"186","author":"I Eisensehr","year":"2001","unstructured":"Eisensehr I, Lindeiner HV, Jager M, Noachtar S: REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson\u2019s disease:is there a need for polysomnography. J Neurol Sci 2001, 186:7\u201311.","journal-title":"J Neurol Sci"},{"key":"73_CR37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1212\/WNL.51.2.363","volume":"51","author":"BF Boeve","year":"1998","unstructured":"Boeve BF, Silber MH, Ferman TJ, et al.: REM sleep behavior disorder and degenerative dementia. An association likely reflecting Lewy body disease. Neurology 1998, 51:363\u2013370.","journal-title":"Neurology"},{"key":"73_CR38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.48.4.1094","volume":"48","author":"G Plazzi","year":"1997","unstructured":"Plazzi G, Corsini R, Peirangeli G, et al.: REM sleep behavior disorders in multiple system atrophy. Neurology 1997, 48:1094\u20131097.","journal-title":"Neurology"},{"key":"73_CR39","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1212\/WNL.39.11.1519","volume":"39","author":"A Culebras","year":"1989","unstructured":"Culebras A, Moore JT: Magnetic resonance findings in REM sleep behavior disorder. Neurology 1989, 39:1519\u20131523.","journal-title":"Neurology"},{"key":"73_CR40","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/WNL.55.9.1410","volume":"55","author":"RL Albin","year":"2000","unstructured":"Albin RL, Koeppe RA, Chervin RD, et al.: Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000, 55:1410\u20131412.","journal-title":"Neurology"},{"key":"73_CR41","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","volume":"123","author":"I Eisensehr","year":"2000","unstructured":"Eisensehr I, Linke R, Noachtar S, et al.: Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder: comparison with Parkinson\u2019s disease and controls. Brain 2000, 123:1155\u20131160.","journal-title":"Brain"},{"key":"73_CR42","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","volume":"84","author":"E Hirsch","year":"1987","unstructured":"Hirsch E, Graybiel AM, Duyckaerts C, Javoy-Agid F: Neuronal loss in the pedunculopontine nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A 1987, 84:5976\u20135980.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"73_CR43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.410340514","volume":"34","author":"CL Comella","year":"1993","unstructured":"Comella CL, Tanner CM, Ristanovic RK: Polysomnographic sleep measures in Parkinson\u2019s disease patients with treatment-induced hallucinations. Ann Neurol 1993, 34:710\u2013714.","journal-title":"Ann Neurol"},{"key":"73_CR44","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","volume":"123","author":"G Fenelon","year":"2000","unstructured":"Fenelon G, Mahieux F, Huon R, Ziegler M: Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors. Brain 2000, 123:733\u2013745. This is one of the largest studies to assess the risk factors for drug-induced hallucinations in Parkinson\u2019s disease.","journal-title":"Brain"},{"key":"73_CR45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0","volume":"14","author":"EJ Pappert","year":"1999","unstructured":"Pappert EJ, Goetz CG, Niederman FG, et al.: Hallucinations, sleep fragmentation and altered dream phenomena in Parkinson\u2019s disease. Mov Disord 1999, 14:117\u2013121.","journal-title":"Mov Disord"},{"key":"73_CR46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-198205020-00003","volume":"5","author":"P Nausieda","year":"1982","unstructured":"Nausieda P, Weiner W, Kaplan L, et al.: Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 1982, 5:183\u2013194.","journal-title":"Clin Neuropharmacol"},{"key":"73_CR47","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.58.3.498","volume":"58","author":"S Overeem","year":"2002","unstructured":"Overeem S, van Hilten JJ, Ripley B, et al.: Normal hypocretin-1 levels in Parkinson disease patients with excessive daytime sleepiness. Neurology 2002, 58:498\u2013499.","journal-title":"Neurology"},{"key":"73_CR48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.149.4.443","volume":"149","author":"JL Cummings","year":"1992","unstructured":"CummingsJL: Depression and Parkinson\u2019s disease: a review. Am J Psychiatry 1992, 149:443\u2013454.","journal-title":"Am J Psychiatry"},{"key":"73_CR49","first-page":"M210","volume":"46","author":"D Blazer","year":"1991","unstructured":"Blazer D, Burchett, Service C, George JK: The association of age and depression among the elderly: an epidemiologic exploration. J Gerontol B Psychol Sci Soc Sci 1991, 46:M210-M215.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"73_CR50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1600-0404.2001.00024.x","volume":"104","author":"S Happe","year":"2001","unstructured":"Happe S, Schrode B, Faltl M, et al.: Sleep disorders and depression in patients with Parkinson disease. Acta Neurol Scand 2001, 104:275\u2013280.","journal-title":"Acta Neurol Scand"},{"key":"73_CR51","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0022-5347(05)67048-6","volume":"164","author":"I Araki","year":"2000","unstructured":"Araki I, Kitahara M, Oida T, Kuno S: Voiding dysfunction and Parkinson\u2019s disease: urodynamic abnormalities and urinary symptoms. J Urol 2000, 164:1640\u20131643.","journal-title":"J Urol"},{"key":"73_CR52","first-page":"498","volume":"12","author":"UK Madopar CR Study Group","year":"1989","unstructured":"UK Madopar CR Study Group: A comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early-morning disability in Parkinson\u2019s Disease. Clin Neuropharmacol 1989, 12:498\u2013505.","journal-title":"Clin Neuropharmacol"},{"key":"73_CR53","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.46.4.1059","volume":"46","author":"R Pahwa","year":"1996","unstructured":"Pahwa R, Lyons K, McGuire D, et al.: Early morning akinesia in Parkinson\u2019s disease: effect of standard carbidopa\/levodopa and sustained-release carbidopa\/levodopa. Neurology 1996, 46:1059\u20131062.","journal-title":"Neurology"},{"key":"73_CR54","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1212\/WNL.51.6.1599","volume":"51","author":"CJ Earley","year":"1998","unstructured":"Earley CJ, Yaffee JB, Allen RP: Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 1998, 51:1599\u20131602.","journal-title":"Neurology"},{"key":"73_CR55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/1531-8257(199901)14:1<138::AID-MDS1023>3.0.CO;2-A","volume":"14","author":"W Ondo","year":"1999","unstructured":"OndoW: Ropinirole for restless legs syndrome. Movement Dis 1999, 14:138\u2013140.","journal-title":"Movement Dis"},{"key":"73_CR56","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1212\/WNL.55.6.870","volume":"55","author":"JM Ringman","year":"2000","unstructured":"Ringman JM, Simmons JH: Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 2000, 55:870\u2013871.","journal-title":"Neurology"},{"key":"73_CR57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1212\/WNL.55.6.789","volume":"55","author":"CG Goetz","year":"2000","unstructured":"Goetz CG, Blasucci LM, Leurgans S, Pappert EJ: Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Neurology 2000, 55:789\u2013794.","journal-title":"Neurology"},{"key":"73_CR58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00004714-200002000-00010","volume":"20","author":"SD Targun","year":"2000","unstructured":"Targun SD, Abbott JL: Efficacy of quetiapine in Parkinson\u2019s patients with psychosis. J Clin Psychopharmacol 2000, 20:54\u201360.","journal-title":"J Clin Psychopharmacol"},{"key":"73_CR59","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/1531-8257(199911)14:6<922::AID-MDS1003>3.0.CO;2-7","volume":"14","author":"E Tandberg","year":"1999","unstructured":"Tandberg E, Larsen JP, Karlsen K: Excessive daytime sleepiness and sleep benefit in Parkinson\u2019s disease: a community based study. Mov Disord 1999, 14:922\u2013927.","journal-title":"Mov Disord"},{"key":"73_CR60","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1212\/WNL.52.9.1908","volume":"52","author":"S Frucht","year":"1999","unstructured":"Frucht S, Rogers JD, Greene PE, et al.: Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999, 52:1908\u20131910.","journal-title":"Neurology"},{"key":"73_CR61","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1212\/WNL.57.8.1392","volume":"57","author":"WG Ondo","year":"2001","unstructured":"Ondo WG, Dat Vuong K, Kahn H, et al.: Daytime sleepiness and other sleep disorders in Parkinson\u2019s disease. Neurology 2001, 57:1392\u20131396.","journal-title":"Neurology"},{"key":"73_CR62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2869.2000.00201.x","volume":"9","author":"DB Rye","year":"2000","unstructured":"Rye DB, Bliwise DL, Dihenia B, Gurecki P: Daytime sleepiness in Parkinson\u2019s disease. J Sleep Res 2000, 9:63\u201369.","journal-title":"J Sleep Res"},{"key":"73_CR63","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","volume":"342","author":"O Rascol","year":"2000","unstructured":"Rascol O, Brooks D, Korcyn AD, et al., for the 056 Study Group: A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa. N Engl J Med 2000, 342:1484\u20131491.","journal-title":"N Engl J Med"},{"key":"73_CR64","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","volume":"284","author":"Parkinson Study Group","year":"2000","unstructured":"Parkinson Study Group: Pramipexole vs. levodopa as initial treatment for Parkinson\u2019s disease: a randomized controlled trial. JAMA 2000, 284:1931\u20131938.","journal-title":"JAMA"},{"key":"73_CR65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s007020170098","volume":"108","author":"S Pal","year":"2001","unstructured":"Pal S, Bhattacharya KF, Agapito C, Chaudhuri KR: A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson\u2019s disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 2001, 108:71\u201377. This study finds that both Parkinson\u2019s disease patients and normal control subjects report sudden onset of sleep or \"sleep attacks,\" suggesting that the phenomenon is more frequent but not unique to the Parkinson\u2019s disease population taking dopaminergic medications.","journal-title":"J Neural Transm"},{"key":"73_CR66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.58.3.465","volume":"58","author":"EK Tan","year":"2002","unstructured":"Tan EK, Lum SY, Fogle-Chong SM, et al.: Evaluation of somnolence in Parkinson\u2019s disease: comparison with age- and sex-matched controls. Neurology 2002, 58:465\u2013468.","journal-title":"Neurology"},{"key":"73_CR67","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/WNL.58.10.1544","volume":"58","author":"MD Gjerstad","year":"2002","unstructured":"Gjerstad MD, Aaesland D, Larsen JD: Development of daytime somnolence over time in Parkinson\u2019s disease. Neurology 2002, 58:1544\u20131546.","journal-title":"Neurology"},{"key":"73_CR68","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.1083","volume":"16","author":"F Tracik","year":"2001","unstructured":"Tracik F, Ebersbach G: Sudden daytime sleep onset in Parkinson\u2019s Disease: polysomnographic recordings. Mov Disord 2001, 16:500\u2013506.","journal-title":"Mov Disord"},{"key":"73_CR69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00002826-200203000-00010","volume":"25","author":"AV Nieves","year":"2002","unstructured":"Nieves AV, Lang AE: Treatment of excessive daytime sleepiness in patients with Parkinson\u2019s disease with modafinil. Clin Neuropharmacol 2002, 25:111\u2013114.","journal-title":"Clin Neuropharmacol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-003-0073-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0073-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:24:30Z","timestamp":1559435070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-003-0073-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1007\/s11910-003-0073-2","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}